Dr. Sushama R. Chaphalkar

PhD in Microbiology

Biotechnology, Microbiology

Dr. Sushama R. Chaphalkar is a senior researcher and academician based in Pune, India. She holds a PhD in Microbiology and comes with vast experience in research and education in Biotechnology. In her illustrious career spanning three decades and a half, she held prominent leadership positions in academia and industry. As the Founder-Director of a renowned Biotechnology institute, she worked extensively on high-end research projects of industrial significance, fostering a stronger bond between industry and academia.

Dr. Chaphalkar is passionate about sustainable development through Biotechnology and brought about significant agrarian development in parts of rural Maharashtra, through her 11-year-long project titled “Biovillage,” which involved need-based research as well as training of the rural population, especially farmers. When she is not working or mentoring students, she finds joy in avid reading, music, gardening, culinary adventures, and exploring new destinations through travel.

See less

Articles from Sushama R.

Study shows ritonavir-boosted nirmatrelvir remains effective against new omicron variants in the U.S

The effectiveness of ritonavir-boosted nirmatrelvir (NMV-r) against Omicron variants.

13 Feb 2024

Drug repurposing study finds lonafarnib effective against RSV

A study in Nature Communications identifies lonafarnib from the ReFRAME drug-repurposing library as a potent inhibitor of the RSV fusion protein, showing promise in reducing RSV infection in vitro and in vivo.

11 Feb 2024

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

A PLOS Pathogens study reveals 4’-fluorouridine effectively combats avian influenza in vitro and in animal models, showing promise as a treatment that overcomes resistance and reduces disease severity without significant adverse effects.

11 Feb 2024

Study explores traditional Atlantic diets as a potential solution for diet-related diseases and environmental sustainability

Researchers from Spain investigated the effect of a traditional Atlantic diet on health and the environment.

8 Feb 2024

AMG 133 (maridebart cafraglutide) weight loss drug shows promise in early trial

AMG 133, an engineered bispecific molecule, demonstrated significant weight loss with a favorable safety profile in a phase 1 clinical trial, offering a promising new treatment option for obesity.

7 Feb 2024

The health effects of using gaseous fuels for household cooking and heating

Researchers examined the evidence on the health effects of the use of gaseous fuels for heating and cooking in various countries.

6 Feb 2024

AI-enabled self-referral system may bridge the accessibility gap for ethnic and gender minorities in mental health treatment

Researchers assessed the impact of an artificial intelligence (AI)-powered self-referral chatbot on diversity and volume of patient referrals in gender, ethnicity, and sexual orientation.

5 Feb 2024